Stay updated on Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Sign up to get notified when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.

Latest updates to the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has been updated to include new information about the study on osteoarthritis, specifically mentioning the EudraCT number and the revision version. However, significant details regarding the study's objectives and inclusion/exclusion criteria have been removed.SummaryDifference15%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check95 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.